Metabolic reprogramming: A novel therapeutic target in diabetic kidney diseaseMengdi Wang, Wenjing Zhao, Zhen Cai et al.|Frontiers in Pharmacology|2022Cited by 41
BaoShenTongLuo formula protects against podocyte injury by regulating AMPK-mediated mitochondrial biogenesis in diabetic kidney diseaseYifan Guo, Wenjing Zhao, Mengdi Wang et al.|Chinese Medicine|2023Cited by 15
Baoshentongluo Formula relieves podocyte injury in diabetic kidney disease through regulating mitophagy via PINK1/Parkin signaling pathwayYanyu Pang, Wenjing Zhao, Lei Tian et al.|Frontiers in Endocrinology|2025Cited by 2
BaoShenTongLuo formula protects against podocyte injury by regulating AMPK-mediated mitochondrial biogenesis in diabetic kidney disease.Yifan Guo, Wenjing Zhao, Mengdi Wang et al.|Research Square|2023Cited by 1